Regeneron Pharmaceuticals SVP Controller Jason Pitofsky Sells $3.83M of Stock
Jason Pitofsky, SVP Controller, sold 4,062 shares of Regeneron Pharmaceuticals, Inc. at $939.57 to $950.76 a share (average $942.19) in 8 transactions, worth $3.83M in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).
Regeneron Pharmaceuticals Insider Huda Y. Zoghbi Sells $7.22M of Stock
Huda Y. Zoghbi sold 7,439 shares of Regeneron Pharmaceuticals, Inc. at $970.42 to $971.06 a share (average $970.46) in 2 transactions, worth $7.22M in total on Nov 3, 2026. Shares held after the trade: 1,703 (-22.7%).
Regeneron Pharmaceuticals Insider George L. Sing Sells $20.4M of Stock
George L. Sing sold 21,129 shares of Regeneron Pharmaceuticals, Inc. at $960.57 to $970.18 a share (average $964.38) in 9 transactions, worth $20.4M in total on Nov 2, 2026. Shares held after the trade: 25,147 (-0.8%).
Regeneron Pharmaceuticals Insider Christine A. Poon Sells $7.59M of Stock
Christine A. Poon sold 7,830 shares of Regeneron Pharmaceuticals, Inc. at $966.74 to $971.31 a share (average $969.09) in 6 transactions, worth $7.59M in total on Nov 2, 2026. Shares held after the trade: 5,219 (-3.7%).
Regeneron Pharmaceuticals EVP General Counsel and Secret Joseph J. Larosa Sells $4.31M of Stock
Joseph J. Larosa, EVP General Counsel and Secret, sold 4,466 shares of Regeneron Pharmaceuticals, Inc. at $965.41 to $966.11 a share (average $965.49) in 2 transactions, worth $4.31M in total on Nov 2, 2026. Shares held after the trade: 38,906 (-1.3%).
Regeneron Pharmaceuticals Insider Kathryn Guarini Sells $360K of Stock
Kathryn Guarini sold 400 shares of Regeneron Pharmaceuticals, Inc. at $900.00 a share, worth $360K in total on Oct 30, 2026. Shares held after the trade: 603 (-39.9%).
Regeneron Pharmaceuticals Insider Michael S. Brown Sells $1.69M of Stock
Michael S. Brown sold 1,929 shares of Regeneron Pharmaceuticals, Inc. at $875.00 a share, worth $1.69M in total on Oct 30, 2026. Shares held after the trade: 1,380 (-58.3%).
Regeneron Pharmaceuticals EVP Commercial Marion McCourt Sells $984K of Stock
Marion McCourt, EVP Commercial, sold 1,132 shares of Regeneron Pharmaceuticals, Inc. at $869.43 a share, worth $984K in total on Oct 30, 2026. Shares held after the trade: 10,871 (-9.4%).